๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Human pharmacokinetics of betaxolol enantiomers

โœ Scribed by Grazia Stagni; Patrick J. Davis; Thomas M. Ludden

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
448 KB
Volume
80
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pharmacokinetics of acebutolol enantiome
Pharmacokinetics of acebutolol enantiomers in humans
โœ Micheline Piquette-Miller; Robert T. Foster; Chulani T. Kappagoda; Fakhreddin Ja ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 460 KB

The chiral beta-blocker acebutolol (AC) is marketed as a racemic mixture. Both AC and its major metabolite, diacetotol (DC), are chiral, the S-enantiomer possessing beta-blocking activity. The pharmacokinetics of AC and DC enantiomers was determined in 12 healthy subjects following oral administrati

Pharmacokinetics of reboxetine enantiome
Pharmacokinetics of reboxetine enantiomers in the dog
โœ E. Frigerio; A. Benecchi; G. Brianceschi; C. Pellizzoni; I. Poggesi; M. Strolin ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 139 KB ๐Ÿ‘ 2 views

Reboxetine, (RS)-2-[(RS)-alpha-(2-ethoxyphenoxy)benzyl]morpholine methanesulphonate, is a racemic compound and consists of a mixture of the (R,R)- and (S,S)-enantiomers. The pharmacokinetics of reboxetine enantiomers were determined in a crossover study in three male beagle dogs. Each animal receive